<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32710206</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Which are the factors influencing NIV adaptation and tolerance in ALS patients?</ArticleTitle><Pagination><StartPage>1023</StartPage><EndPage>1029</EndPage><MedlinePgn>1023-1029</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04624-x</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a multisystemic disease compromising both the neuromuscular system and the cognitive status. Non-invasive ventilation (NIV) has been shown to improve survival and quality of life in ALS patients with respiratory failure, but scanty literature investigated which are the predictors of NIV tolerance. The aim of this study was to evaluate the impact of functional, cognitive, neurobehavioral, and respiratory status on NIV compliance and tolerance in patients with ALS. We retrospectively evaluated clinical data of ALS patients who consecutively underwent a NIV trial during hospitalization. Cognitive and neurobehavioral assessments have been performed using the Edinburgh Cognitive and Behavioral ALS Screen (ECAS), the Hospital Anxiety and Depression Scale (HADS), the Frontal Assessment Battery (FAB), the Raven's 47 Colored Progressive Matrices (PM47), and the Neurobehavioral Rating Scale Revised (NRSR). Seventy-two patients (mean age &#xb1; SD; 63.9 &#xb1; 10.6 years) were included. Patients adapted were 63/72 (87.5%). The average time of adaptation was 7.82 &#xb1; 5.27 days. The time required to reach a satisfying NIV adaptation was significantly related to the presence of sialorrhea (p = 0.02), respiratory status (Borg Dyspnoea Scale, p = 0.006, and ALS-FRS-R respiratory subscore, p = 0.03) and behavioral and cognitive impairment (NRSR-F1, p = 0.04, NRSR- F5, p = 0.04). Presence of sialorrhea and neurobehavioral impairment, and absence of respiratory symptoms are negative predictors of NIV adaptation. This study highlights the need of a multidisciplinary patient-tailored approach including cognitive-behavioral assessment and a psychological support program to optimize patient's training and compliance to NIV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Profazio</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nemo Sud Clinical Center for Neuromuscular Disorders, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Foresta</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nemo Sud Clinical Center for Neuromuscular Disorders, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faraone</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nemo Sud Clinical Center for Neuromuscular Disorders, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lizio</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicenter, Serena Onlus Foundation, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vita</LastName><ForeName>Gian Luca</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Nemo Sud Clinical Center for Neuromuscular Disorders, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sframeli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nemo Sud Clinical Center for Neuromuscular Disorders, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aric&#xf2;</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Nemo Sud Clinical Center for Neuromuscular Disorders, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggeri</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pulmonology Unit, Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toscano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vita</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5204-7826</Identifier><AffiliationInfo><Affiliation>Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. vitag@unime.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nemo Sud Clinical Center for Neuromuscular Disorders, University Hospital "G. Martino", Messina, Italy. vitag@unime.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunetta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicenter, Serena Onlus Foundation, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nemo Sud Clinical Center for Neuromuscular Disorders, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063087" MajorTopicYN="Y">Noninvasive Ventilation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Compliance</Keyword><Keyword MajorTopicYN="N">Multidisciplinary setting</Keyword><Keyword MajorTopicYN="N">Neurobehavioral status</Keyword><Keyword MajorTopicYN="N">Non-invasive ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32710206</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04624-x</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04624-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17085</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41:118&#x2013;130</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, Mazzini L, Mora G, PARALS study group (2011) Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82:740&#x2013;746</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MHB, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, Scott KM, Scotton WJ, Seelen M, Shaw CE, Sidle KS, Swingler R, Tsuda M, Veldink JH, Visser AE, van den Berg LH, Pearce N (2014) Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 13:1108&#x2013;1113</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Iannaccone S, Cerami C, Frasson P, Lacerenza M, Lunetta C, Corbo M, Cappa SF (2013) The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria. Behav Neurol 27:143&#x2013;153</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/126010</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S, Canosa A, Chi&#xf2; A (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86:168&#x2013;173</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H, ALS COSMOS (2016) Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology. 86:813&#x2013;820</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002305</ArticleId></ArticleIdList></Reference><Reference><Citation>Benbrika S, Desgranges B, Eustache F, Viader F (2019) Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: a review. Front Neurosci 13:951</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00951</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboussouan LS, Mireles-Cabodevila E (2013) Respiratory support in patients with amyotrophic lateral sclerosis. Respir Care 58:1555&#x2013;1558</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.02710</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N (2017) Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 10:CD004427</Citation><ArticleIdList><ArticleId IdType="pubmed">28982219</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5:140&#x2013;147</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70326-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM (2007) Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler 8:185&#x2013;188</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701262392</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Lu&#xed;s ML (1995) Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci 129(Suppl):19&#x2013;26</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(95)00052-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T (1999) Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 164:82&#x2013;88</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00045-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H (1997) Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 127:450&#x2013;453</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-127-6-199709150-00006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A (2006) Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 67:761&#x2013;765</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000227785.73714.64</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyall RA, Donaldson N, Fleming T, Wood C, Newsom-Davis I, Polkey MI, Leigh PN, Moxham J (2001) A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 57:153&#x2013;156</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.1.153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ (2003) Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 61:171&#x2013;177</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000076182.13137.38</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL (2005) Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve 32:808&#x2013;811</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20415</ArticleId></ArticleIdList></Reference><Reference><Citation>Volanti P, Cibella F, Sarv&#xe0; M, De Cicco D, Spanevello A, Mora G, La Bella V (2011) Predictors of non-invasive ventilation tolerance in amyotrophic lateral sclerosis. J Neurol Sci 303:114&#x2013;118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.12.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H (2001) Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 24:403&#x2013;409</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4598(200103)24:3&lt;403::AID-MUS1013&gt;3.0.CO;2-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelot-Panzini C, Bruneteau G, Gonzalez-Bermejo J (2019) NIV in amyotrophic lateral sclerosis: the &#x2018;when&#x2019; and &#x2018;how&#x2019; of the matter. Respirology 24:521&#x2013;530</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.13525</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlesimo GA, Caltagirone C, Gainotti G (1996) The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36:378&#x2013;384</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000117297</ArticleId></ArticleIdList></Reference><Reference><Citation>Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli P (2005) The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108&#x2013;116</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-005-0443-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15:9&#x2013;14</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361&#x2013;370</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69&#x2013;77</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(01)00296-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanier M, Mazaux JM, Lambert J, Dassa C, Levin HS (2000) Assessment of neuropsychologic impairments after head injury: interrater reliability and factorial and criterion validity of the Neurobehavioral Rating Scale-Revised. Arch Phys Med Rehabil 81:796&#x2013;806</Citation><ArticleIdList><ArticleId IdType="pubmed">10857527</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Force AET (2005) Standardisation of spirometry. Eur Respir J 26:319&#x2013;338</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00034805</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J, Initiative ERSGLF (2012) Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 40:1324&#x2013;1343</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson SH, Cooke NT, Edwards RH, Spiro SG (1984) Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax 39:535&#x2013;538</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.39.7.535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick KR, Baxi SC, Smith RM (2000) Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs 26:216&#x2013;222</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0099-1767(00)90093-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138:923&#x2013;936</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a116813</ArticleId></ArticleIdList></Reference><Reference><Citation>Copper A, Weekes TJ (1983) Data, models, and statistical analysis, Rowman &amp; Littlefield, pp 50-51.</Citation></Reference><Reference><Citation>Tysnes O-B (2008) Treatment of sialorrhea in amyotrophic lateral sclerosis. Acta Neurol Scand 188:77&#x2013;81</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2008.01037.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Garuti G, Rao F, Ribuffo V, Sansone VA (2019) Sialorrhea in patients with ALS: current treatment options. Degener Neurol Neuromuscul Dis 9:19&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pubmed">31118868</ArticleId><ArticleId IdType="pmc">6498144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontis TC, Johns ME (2006) Anatomy and physiology of the salivary glands. In: Bailay BJ (ed) Head and Neck Surgery Otolaryngology, 4th ed. Lippincott Williams &amp; Wilkins, Philadelphia, pp 531&#x2013;539</Citation></Reference><Reference><Citation>Chi&#xf2; A, Ilardi A, Cammarosano S, Moglia C, Montuschi A, Calvo A (2012) Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 78:1085&#x2013;1089</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31824e8f53</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society (1999) Am J Respir Crit Care Med 159:321-340</Citation></Reference><Reference><Citation>Manera U, Torrieri MC, Moglia C, Viglione M, Daviddi MAR, Matteoni E, Solero L, Palumbo F, Vasta R, Canosa A, D&#x2019;Ovidio F, Focaraccio L, Mattei A, Mora G, Calvo A, Chi&#xf2; A (2020) The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitorin. J Neurol Neurosurg Psychiatry 2020</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>